Literature DB >> 24852178

Survey on the current trends in managing intrauterine growth restriction.

Stefan Savchev1, Francesc Figueras, Eduard Gratacos.   

Abstract

OBJECTIVE: To provide a snapshot of the current trends in managing intrauterine growth restriction (IUGR) and to assess the agreement on the gestational age and the way of delivery in different clinical scenarios.
METHODS: A PubMed search was performed to identify all original articles on IUGR in the last 6 years. The most active 20 authors were selected as experts and were invited to respond to a survey on their preferred gestational age for elective delivery in several IUGR cases depending on Doppler measurements (including umbilical artery (UA), middle cerebral artery, cerebroplacental ratio, uterine artery and ductus venosus), biophysical profile and cardiotocography.
RESULTS: 15 of the 20 selected experts agreed to participate in the survey, of which 3 failed to meet the deadline to complete the survey. Management of IUGR was relatively uniform for abnormal UA, uterine artery or cerebroplacental ratio. Although average gestational age at delivery reflected a clear progression with accepted markers of severity, discrepancies of up to 4 weeks were found for abnormal middle cerebral artery Doppler and absent end-diastolic velocity in the UA, and of up to 8 weeks for reverse end-diastolic velocity in the UA and abnormalities in the ductus venosus Doppler.
CONCLUSIONS: Management of IUGR is still far from being uniform among centers, with most controversy surrounding the management of early-onset IUGR. There is a need of prospective studies to address this issue.

Entities:  

Mesh:

Year:  2014        PMID: 24852178     DOI: 10.1159/000360419

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  6 in total

1.  Intermediate Diastolic Velocity as a Parameter of Cardiac Dysfunction in Growth-Restricted Fetuses.

Authors:  Xiangna Tang; Edgar Hernandez-Andrade; Hyunyoung Ahn; Maynor Garcia; Homam Saker; Steven J Korzeniewski; Adi L Tarca; Lami Yeo; Sonia S Hassan; Roberto Romero
Journal:  Fetal Diagn Ther       Date:  2015-08-12       Impact factor: 2.587

2.  Assessment of body composition in Wistar rat offspring by DXA in relation to prenatal and postnatal nutritional manipulation.

Authors:  Makarios Eleftheriades; Homeira Vafaei; Ismene Dontas; George Vaggos; Katerina Marinou; Panagiota Pervanidou; Neil J Sebire; George P Chrousos; Kypros H Nicolaides
Journal:  Pediatr Res       Date:  2016-04-08       Impact factor: 3.756

3.  The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy E Whitten; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2016

4.  Multidisciplinary consensus on screening for, diagnosis and management of fetal growth restriction in the Netherlands.

Authors:  Viki Verfaille; Ank de Jonge; Lidwine Mokkink; Myrte Westerneng; Henriëtte van der Horst; Petra Jellema; Arie Franx
Journal:  BMC Pregnancy Childbirth       Date:  2017-10-16       Impact factor: 3.007

5.  Mitochondrial implications in human pregnancies with intrauterine growth restriction and associated cardiac remodelling.

Authors:  Mariona Guitart-Mampel; Diana L Juarez-Flores; Lina Youssef; Constanza Moren; Laura Garcia-Otero; Vicente Roca-Agujetas; Marc Catalan-Garcia; Ingrid Gonzalez-Casacuberta; Ester Tobias; José C Milisenda; Josep M Grau; Fàtima Crispi; Eduard Gratacos; Francesc Cardellach; Glòria Garrabou
Journal:  J Cell Mol Med       Date:  2019-04-02       Impact factor: 5.310

6.  Introducing a Mobile-Connected Umbilical Doppler Device (UmbiFlow™) into a Primary Care Maternity Setting: Does This Reduce Unnecessary Referrals to Specialised Care? Results of a Pilot Study in Kraaifontein, South Africa.

Authors:  Josef Mufenda; Stefan Gebhardt; Rita van Rooyen; Gerhard Theron
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.